ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 188,49
0,00%
Dow Jones
39 869,38
-0,10%
DAX
18 738,81
-0,72%
Brent Oil
83,295
0,11%
Bitcoin
65 508,74
0,41%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Kiromic BioPharma Inc (KRBP)

  7. Kiromic BioPharma Inc (KRBP) Actualités

KRBP

Kiromic BioPharma (KRBP)

Kiromic BioPharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:KRBP
DateHeureSourceTitreSymboleSociété
24/04/202414h08Business WireKiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three PatientsNASDAQ:KRBPKiromic BioPharma Inc
19/04/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
10/04/202422h30Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:KRBPKiromic BioPharma Inc
02/04/202414h18Business WireKiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
21/03/202422h21Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:KRBPKiromic BioPharma Inc
20/03/202422h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
19/03/202413h08Business WireEarly Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
01/03/202414h08Business WireKiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 TrialNASDAQ:KRBPKiromic BioPharma Inc
29/02/202400h30Business WireKiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7thNASDAQ:KRBPKiromic BioPharma Inc
14/02/202414h08Business WireResults from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two MonthsNASDAQ:KRBPKiromic BioPharma Inc
29/01/202413h47Business WireKiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung CancerNASDAQ:KRBPKiromic BioPharma Inc
05/01/202414h08Business WireKiromic BioPharma Reports Favorable Early Safety and Tolerability Data from First Patient Enrolled in the Phase 1 Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
14/12/202314h17Business Wire Kiromic BioPharma Announces First Patient Dosed in Phase 1 Study Evaluating Deltacel™ for the Treatment of Non-Small Cell Lung CancerNASDAQ:KRBPKiromic BioPharma Inc
13/09/202322h35Business WireKiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14NASDAQ:KRBPKiromic BioPharma Inc
15/08/202322h16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KRBPKiromic BioPharma Inc
14/08/202322h52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRBPKiromic BioPharma Inc
10/08/202318h28Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
24/07/202321h00Business WireKiromic BioPharma Welcomes Two New Directors to its BoardNASDAQ:KRBPKiromic BioPharma Inc
18/07/202322h22Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRBPKiromic BioPharma Inc
29/06/202322h34Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:KRBPKiromic BioPharma Inc
29/06/202322h33Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:KRBPKiromic BioPharma Inc
27/06/202322h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KRBPKiromic BioPharma Inc
19/05/202322h50Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:KRBPKiromic BioPharma Inc
15/05/202323h14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KRBPKiromic BioPharma Inc
01/05/202314h08Business WireKiromic BioPharma Announces FDA Authorization of IND to Initiate Phase 1 Clinical Trial Evaluating Deltacel in Non-Small Cell Lung CancerNASDAQ:KRBPKiromic BioPharma Inc
28/04/202323h08Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:KRBPKiromic BioPharma Inc
17/04/202323h07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:KRBPKiromic BioPharma Inc
03/04/202314h08Business WireKiromic BioPharma Submits Investigational New Drug Application for Phase 1 Trial with Deltacel for Non-Small Cell Lung CancerNASDAQ:KRBPKiromic BioPharma Inc
31/03/202322h49Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:KRBPKiromic BioPharma Inc
10/03/202322h30Business WireKiromic BioPharma Announces Reverse Stock SplitNASDAQ:KRBPKiromic BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:KRBP

Dernières Valeurs Consultées

DBI
Q6TB
SDAX 10 Capped
COIN
BUXEUR
BUX Token
NASDAQ
OPENW
Opendoor Technologies
LSE
LR95
Citi Fun 29
BIT
UC3JRH
Unicredit Bank
LSE
SG18
Morg.st.b.v 24
BIT
UC562V
Unicredit Bank
BIT
F15503
Vontobel Financial Produ...
BIT
UB87MU
Unicredit Bank
BIT
UC6Y54
Unicredit Bank
COIN
STNBTC
Stone Token
BIT
UC3T3P
Unicredit Bank
BIT
UC2Q25
Unicredit Bank
BIT
STES3S
Sg Issuer
NASDAQ
ANDAR
Andina Acquisition Corpo...
ASX
TT6HC
Triton Bond Trust 2021 1...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés